n,n-dimethylarginine has been researched along with vildagliptin in 1 studies
| Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (vildagliptin) | Trials (vildagliptin) | Recent Studies (post-2010) (vildagliptin) |
|---|---|---|---|---|---|
| 2,216 | 228 | 1,221 | 793 | 186 | 566 |
| Protein | Taxonomy | n,n-dimethylarginine (IC50) | vildagliptin (IC50) |
|---|---|---|---|
| Dipeptidyl peptidase 9 | Bos taurus (cattle) | 0.68 | |
| Dipeptidyl peptidase IV | Porphyromonas gingivalis | 1.3 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.1496 | |
| Dipeptidyl peptidase 4 | Mus musculus (house mouse) | 0.051 | |
| Prolyl endopeptidase FAP | Homo sapiens (human) | 2.497 | |
| Dipeptidyl peptidase 8 | Homo sapiens (human) | 3.0627 | |
| Dipeptidyl peptidase 9 | Homo sapiens (human) | 0.4224 | |
| Dipeptidyl peptidase 2 | Homo sapiens (human) | 0.051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul-Ghani, M; Cakirca, M; Camli, AA; Cikrikcioglu, MA; Erkoc, R; Hursitoglu, M; Kanat, M; Karatoprak, C; Kiskac, M; Soysal, P; Zorlu, M | 1 |
1 trial(s) available for n,n-dimethylarginine and vildagliptin
| Article | Year |
|---|---|
Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients.
Topics: Adamantane; Adult; Aged; Arginine; C-Reactive Protein; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Combinations; Female; Fibrinogen; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Nitric Oxide; Nitriles; Pyrrolidines; Vildagliptin | 2014 |